Mathew Blackman
Stock Analyst at Stifel
(4.54)
# 286
Out of 4,761 analysts
54
Total ratings
58.97%
Success rate
22.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Hold | $245 → $293 | $282.80 | +3.61% | 3 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $80.28 | +17.09% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $17.95 | +33.70% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.65 | +81.82% | 1 | Oct 17, 2024 | |
| PEN Penumbra | Initiates: Buy | $238 | $291.68 | -18.40% | 1 | Sep 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $88.78 | +12.64% | 11 | Aug 23, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $19 → $16 | $10.61 | +50.80% | 5 | Aug 1, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $55 → $60 | $31.00 | +93.55% | 5 | May 29, 2024 | |
| INGN Inogen | Maintains: Hold | $6 → $7 | $9.91 | -29.36% | 12 | May 8, 2024 | |
| CLPT ClearPoint Neuro | Reiterates: Buy | $8 → $9 | $16.72 | -46.17% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $8.45 | +30.18% | 4 | May 10, 2023 |
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $282.80
Upside: +3.61%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $80.28
Upside: +17.09%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $17.95
Upside: +33.70%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.65
Upside: +81.82%
Penumbra
Sep 17, 2024
Initiates: Buy
Price Target: $238
Current: $291.68
Upside: -18.40%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $88.78
Upside: +12.64%
Alphatec Holdings
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $10.61
Upside: +50.80%
Tandem Diabetes Care
May 29, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $31.00
Upside: +93.55%
Inogen
May 8, 2024
Maintains: Hold
Price Target: $6 → $7
Current: $9.91
Upside: -29.36%
ClearPoint Neuro
Mar 13, 2024
Reiterates: Buy
Price Target: $8 → $9
Current: $16.72
Upside: -46.17%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $8.45
Upside: +30.18%